GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (MEX:CRL) » Definitions » Cyclically Adjusted PS Ratio

Charles River Laboratories International (MEX:CRL) Cyclically Adjusted PS Ratio : 2.25 (As of Jun. 02, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Charles River Laboratories International Cyclically Adjusted PS Ratio?

As of today (2025-06-02), Charles River Laboratories International's current share price is MXN4066.92. Charles River Laboratories International's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was MXN1,810.55. Charles River Laboratories International's Cyclically Adjusted PS Ratio for today is 2.25.

The historical rank and industry rank for Charles River Laboratories International's Cyclically Adjusted PS Ratio or its related term are showing as below:

MEX:CRL' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.49   Med: 3.99   Max: 11.01
Current: 2.02

During the past years, Charles River Laboratories International's highest Cyclically Adjusted PS Ratio was 11.01. The lowest was 1.49. And the median was 3.99.

MEX:CRL's Cyclically Adjusted PS Ratio is ranked better than
50.76% of 132 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.065 vs MEX:CRL: 2.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Charles River Laboratories International's adjusted revenue per share data for the three months ended in Mar. 2025 was MXN395.932. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is MXN1,810.55 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Charles River Laboratories International Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Charles River Laboratories International's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charles River Laboratories International Cyclically Adjusted PS Ratio Chart

Charles River Laboratories International Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.60 8.40 4.15 3.99 2.83

Charles River Laboratories International Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.41 3.29 3.08 2.83 2.25

Competitive Comparison of Charles River Laboratories International's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Charles River Laboratories International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's Cyclically Adjusted PS Ratio falls into.


;
;

Charles River Laboratories International Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Charles River Laboratories International's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=4066.92/1810.55
=2.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Charles River Laboratories International's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=395.932/134.9266*134.9266
=395.932

Current CPI (Mar. 2025) = 134.9266.

Charles River Laboratories International Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 112.050 100.684 150.158
201509 124.992 100.392 167.990
201512 127.332 99.792 172.162
201603 128.288 100.470 172.284
201606 167.516 101.688 222.271
201609 171.368 101.861 226.997
201612 199.176 101.863 263.827
201703 173.340 102.862 227.374
201706 175.416 103.349 229.013
201709 174.104 104.136 225.583
201712 192.027 104.011 249.104
201803 183.793 105.290 235.527
201806 234.506 106.317 297.611
201809 221.951 106.507 281.176
201812 242.437 105.998 308.602
201903 237.100 107.251 298.284
201906 254.343 108.070 317.552
201909 265.246 108.329 330.370
201912 261.267 108.420 325.141
202003 331.808 108.902 411.103
202006 313.567 108.767 388.982
202009 323.858 109.815 397.916
202012 306.528 109.897 376.342
202103 330.004 111.754 398.430
202106 354.661 114.631 417.453
202109 357.311 115.734 416.564
202112 359.671 117.630 412.560
202203 354.549 121.301 394.375
202206 381.753 125.017 412.014
202209 387.982 125.227 418.035
202212 417.584 125.222 449.947
202303 360.785 127.348 382.256
202306 353.070 128.729 370.069
202309 346.516 129.860 360.037
202312 335.178 129.419 349.441
202403 323.832 131.776 331.574
202406 362.585 132.554 369.076
202409 385.447 133.029 390.946
202412 407.001 133.157 412.410
202503 395.932 134.927 395.932

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Charles River Laboratories International  (MEX:CRL) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Charles River Laboratories International Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Charles River Laboratories International's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Charles River Laboratories International Business Description

Traded in Other Exchanges
Address
251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.